Company Analysis

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE: MTNB · Pharmaceutical Preparations · Bedminster, NJ · filing with the SEC since 2013
Grade4.4
◀ Past 4.6● Present 2.9▶ Future 5.6
2 est.

Who runs Matinas BioPharma Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
0
of 4 people with a filing in the last fifteen months
Directors reporting now
4
25 people on the record since 2017
Directorssales are open-market, Nov 9, 2025 to Nov 9, 2026
NameRoleFirst filingLatest filingSales, 12 months
D An EvelyndirectorFeb 2025Nov 9, 2026none
Murphy KeithdirectorMar 2025Nov 9, 2026none
Neugeboren EdwarddirectorMar 2025Nov 9, 2026none
Stern Adam KdirectorMar 2017Aug 13, 2026none
Owners of more than 10% of a classsales are open-market, Nov 9, 2025 to Nov 9, 2026
NameRoleFirst filingLatest filingSales, 12 months
Sanitam Partners LLC10% ownerFeb 2025Aug 13, 2026none
Earlier names on the record26, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MTNB · research, not advice